Nan Fung Group Holdings Ltd

Q4 2021 13F Combination Report, Stock Holdings

Signature - Title
Tang Chun Wai Nelson - Director
Location
Kai Tak, Hong Kong
Holdings as of
December 31, 2021
Value $
$338M
Num holdings
55
Date filed
2/14/2022, 09:41 AM
Form type
13F-HR
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s). Top holdings included NFH, ILMN, HRMY, KRTX, and SLGC.
Previous filing
Q3 2021 - Nov 15, 2021
Next filing
Q1 2022 - May 13, 2022
SEC
View on sec.gov
Filing 2021 Q4 compared to 2021 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Tang Chun Wai Nelson Director Central, Hong Kong 2/14/2022

List of Other Managers Reporting for Nan Fung Group Holdings Ltd:

Name Holdings Value Location File Number
Pivotal bioVenture Partners Fund I U.G.P. Ltd San Francisco, CA 028-20631
Pivotal bioVenture Partners Investment Advisor LLC $124M San Francisco, CA 028-20630

Other Included Managers (2):

Num Name Location File Number
1 Pivotal bioVenture Partners Investment Advisor LLC San Francisco, CA 028-20630
2 Pivotal bioVenture Partners Fund I U.G.P. Ltd San Francisco, CA 028-20631